门静脉栓塞术:预测未来残肝肥大的影像学表现
本研究回顾性分析79例右支门静脉栓塞患者,评估影像学表现与未来残肝肥大率的关系。近端细小分支数量、短暂性肝实质强化、门静脉侵犯及主门静脉解剖变异与肥大率显著相关。无显著影像学表现者平均肥大率51.0%(n=16),有至少一项显著表现者25.8%(n=63)。
要点
- 右前及右后门静脉近端细小分支数量与未来残肝肥大率显著相关(p < 0.001)。
- 短暂性肝实质强化、门静脉侵犯及主门静脉解剖变异亦与肥大率显著相关。
- 无显著影像学表现者肥大率51.0%(n=16),有至少一项表现者25.8%(n=63)。
核心结论
- 影像学表现结合既往因素有助于确定门静脉栓塞指征及大范围肝切除新策略。
研究设计与样本
- 回顾性分析2007年7月至2017年4月79例右支门静脉栓塞患者,采用多元线性回归校正潜在混杂因素。
关键影像表现/征象
- 评估的影像学表现包括右叶前段体积比、右前及右后门静脉近端细小分支数量、短暂性肝实质强化、门静脉侵犯及主门静脉解剖变异。
诊断标准与关键数值
- 未来残肝肥大率与右前及右后门静脉近端细小分支数量相关(p < 0.001)。
- 未来残肝肥大率与短暂性肝实质强化相关(p < 0.001)。
- 未来残肝肥大率与门静脉侵犯相关(p = 0.017)。
- 未来残肝肥大率与主门静脉解剖变异相关(p = 0.048)。
临床应用与阅片要点
- 无显著影像学表现者平均未来残肝肥大率为51.0%(n = 16)。
- 有至少一项显著影像学表现者平均未来残肝肥大率为25.8%(n = 63)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE. The purpose of this article is to evaluate the radiologic findings predicting the future liver remnant hypertrophy ratio after portal vein embolization of the right branch. MATERIALS AND METHODS. The associations between the radiologic findings and the future liver remnant hypertrophy ratio for 79 patients who underwent portal vein embolization of the right branch between July 2007 and April 2017 were retrospectively analyzed. Multiple linear regression was performed to adjust for potential confounders, and the volume ratio of the right lobe anterior segment, number of proximal small branches from the right anterior and posterior portal veins, transient hepatic parenchymal enhancement, portal vein invasion, and variants of main portal vein anatomy were evaluated. The potential confounders were age, ratio of future liver remnant hypertrophy to total liver volume, indocyanine green clearance rate, maximum serum total bilirubin before portal vein embolization, and history of chemotherapy. RESULTS. Statistically significant associations were found between the future liver remnant hypertrophy ratio and the number of proximal small branches from the right anterior and posterior portal veins (p < 0.001), transient hepatic parenchymal enhancement (p < 0.001), portal vein invasion (p = 0.017), and variants of main portal vein anatomy (p = 0.048). The mean future liver remnant hypertrophy rate was 51.0% (n = 16) in patients without the radiologic findings showing statistically significant differences, and 25.8% (n = 63) in patients with at least one significant finding. CONCLUSION. When added to previously reported factors, the radiologic findings identified can help determine the indications for portal vein embolization and novel strategies for major hepatectomy.
引用
- Kohno S, Isoda H, Ono A, et al. Portal Vein Embolization: Radiological Findings Predicting Future Liver Remnant Hypertrophy. AJR Am J Roentgenol. 2019. PMID: 31642696. doi:10.2214/AJR.19.21440
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。